The new single-tablet regimen provides a safe and effective treatment option for patients with HIV.
Two recently approved agents offer significant activity against these hard-to-treat conditions.
Erin K. McCreary, PharmD, BCPS, BCIDP; and Jason M. Pogue, PharmD, BCPS, BCIDP, provide an update of published literature on experimental treatments for COVID-19 from the past week.
Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.
This In the Literature piece details a study evaluating the appropriateness of prescriptions in comparison to evidence-based guidelines and expert opinion.
Reports of serious consequences from severe streptococcal infections have caused fear among the general public, but is this fear warranted?
Funded jurisdictions scramble to meet daunting deadlines yet maintain optimism that the new federal initiative can end flat funding and catalyze progress.
Over time we will learn the best utility of the ELISA test, as SARS-CoV-2 is here to stay.
Diagnostic stewardship is a novel concept related to modifying the process of ordering, testing, and reporting with the goal of decreasing unnecessary testing and treatment, working upstream and synergistically with antimicrobial stewardship principles.
In addition to licensed pharmacists, student pharmacists can play an important role in helping more Americans get vaccinated by participating in immunization campaigns throughout their communities.
Optimizing the relationship between infection prevention and antimicrobial stewardship.
Expansion of antimicrobial stewardship strategies to include vertical methods represents an opportunity for programs, both new and established, to further optimize antimicrobial use.
In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.
Shorter durations of antibiotic therapy demonstrate similar efficacy and may improve safety compared with longer courses for certain infections.
A new study confirms the ribavirin steady-state serum levels that correspond to high rates of efficacy and low adverse events.
Novel modes of delivery are imperative to improve HIV suppression and prevent transmission.
Candida auris—Are we prepared for another multidrug-resistant pathogen?
The CDC, WHO, and other global entities are working together to understand and control this novel coronavirus and provide important guidelines for health care professionals. Here’s what you should know.
Both the United Nations and World Health Organization (WHO) discussed the threat of H5N1, and its potential transmission to other mammals and humans.
Children in the United States will be able to avoid potentially millions of hours of at-home quarantining under a testing program unveiled by the CDC today.
SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.
“A bite bug in the belly.”
Recent research shows no clinical benefits from adding azithromycin to standard treatment for adults who presented to emergency departments with acute asthma exacerbations requiring a corticosteroid course.
New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
Fecal microbiota transplantation (FMT) is a widely accepted, safe, and effective treatment for recurrent Clostridium diffi­cile infection (rCDI), but does the cure endure?